| Recruiting | A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising Exercise | Phase 4 | 2026-03-26 |
| Not Yet Recruiting | Gut Microbiome and Metabolic Health Study Healthy Volunteers | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | Glucose Tolerance Study Healthy Volunteers, Glucose Tolerance | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | Sleep and Stress Study Sleep Disorder (Disorder), Stress, Anxiety | Phase 2 | 2026-02-01 |
| Recruiting | A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Absorption of Omega-3, Omega-3 Supplementation, Healthy Participants | Phase 3 | 2025-10-27 |
| Active Not Recruiting | A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA Optimal Absorption of Omega-3, Healthy | Phase 4 | 2025-08-06 |
| Completed | CaroRite™ for Skin Health and Signs of Ageing Healthy Volunteer, Skin Condition, Ageing Signs | Phase 4 | 2025-07-07 |
| Recruiting | Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathy | Phase 2 | 2025-07-01 |
| Completed | M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis Allergic Rhinitis Due to Grass Pollens | Phase 2 | 2025-06-27 |
| Completed | LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases Healthy Volunteer, Immune Response | Phase 3 | 2025-04-29 |
| Completed | LC-Plasma for Preventing URTIs and Reducing Symptoms Healthy Volunteer, URTI | Phase 3 | 2025-03-28 |
| Completed | OEA and LipiSperse Metabolic Study Healthy Volunteers - Male and Female, Pharmacokinetic Study in Healthy Volunteers | Phase 4 | 2025-03-04 |
| Completed | Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Populat Chronic Inflammation, Mobility, Muscle Pain | Phase 3 | 2025-02-27 |
| Recruiting | Long-Term PEA Safety Study Healthy, Safety | Phase 2 | 2025-01-22 |
| Withdrawn | Effect of Fenugreek Fibre on Gut Microbiome Gut Microbiome | Phase 3 | 2024-12-01 |
| Completed | Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults Circulatory; Change | Phase 3 | 2024-10-31 |
| Completed | Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Popula Post Exercise Inflammation, Exercise Recovery, Muscle Fatigue | Phase 3 | 2024-09-12 |
| Completed | Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Fre Lower Urinary Tract Symptoms | Phase 4 | 2024-06-21 |
| Completed | Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain Knee Joint Pain | Phase 4 | 2024-04-24 |
| Completed | Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman Iron-deficiency | Phase 3 | 2024-03-06 |
| Completed | Effect of Maolactin on Gastrointestinal Tract (GIT) Health Gastrointestinal Dysfunction | Phase 3 | 2024-02-21 |
| Completed | Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms Long Covid19 | Phase 3 | 2023-10-25 |
| Completed | Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain Menstrual Pain | Phase 4 | 2023-05-19 |
| Completed | Effectiveness of Food-grown Magnesium on Sleep Quality/Quantity Sleep | Phase 3 | 2023-04-06 |
| Completed | A Study to Determine Optimal Absorption of Single Dose Omega-3 Optimal Gastrointestinal Absorption of Omega-3 | Phase 4 | 2022-08-04 |
| Recruiting | Effect of Testofen on Erectile Function in an Adult Male Population Erectile Dysfunction | Phase 3 | 2022-04-19 |
| Completed | The Effectiveness of a Caralluma Fimbriata Extract on Stress, Sleep and Neurotransmitters Stress, Sleep | Phase 2 / Phase 3 | 2022-02-10 |
| Completed | The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Ecz Eczema, Atopic | Phase 2 / Phase 3 | 2021-11-29 |
| Completed | A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Mig Migraine | Phase 3 | 2021-09-01 |